Andrew P. Bakaj, the firm’s managing partner, appeared on CNN’s Smerconish Saturday, March 27, 2021, to discuss marijuana use and its impact on a security clearance. To watch Andrew’s appearance, click here or the image, below.
Washingtonian Magazine has named Andrew Bakaj among Washington, DC’s top lawyers as well as among Washington’s Most Influential People.
As to the latter, Washingtonian identified 250 experts and advocates – outside the government – who will be shaping the policy debates of the years to come. In identifying those top “influencers”, Washingtonian wrote:
“Policymaking changes as governments come in and out of power. But the bedrock underlying it—expertise that enables public service and good-faith debate and explains why idealists still come to Washington—remains. Here’s a look at who’s wielding that influence right now.”
Click here to see Andrew profiled as a Top Lawyer.
Click here to see Andrew named as one of Washington’s Most Influential People.
On April 14, 2020, The Washington Post published an OpEd written by Andrew Bakaj, the firm’s Managing Partner, and his colleagues Mark Zaid and John Tye. The OpEd discusses the President’s removal of numerous Inspectors General and the need for independent Inspectors General to conduct effective and efficient oversight.
To read the OpEd online, click here.
On April 3, 2020, both Andrew Bakaj and I. Charles McCullough were interviewed by The New York Times about the President’s removal of Intelligence Community Inspector General.
To read the article, please click here.
In February of this year, I. Charles McCullough was interviewed for two articles with ClearanceJobs.com. The first, published on February 10, 2020, Mr. McCullough discusses how a long distance relationship can impact a security clearance. The second article, published on February 24, 2020, discusses the importance on leaving a job on good terms.
To read the February 10, 2020, article, please click here.
To read the February 24, 2020, article, please click here.
On Sunday March 1, 2020, The New York Times published an OpEd written by Andrew Bakaj, the firm’s Managing Partner, and his colleague Mark Zaid. The OpEd discusses the critical need to support and enhance federal whistleblower protections. They concluded writing:
“Whistle-blowers play a particularly critical role in Congress’s ability to oversee the intelligence community. As the executive branch controls classified information, the House and Senate Intelligence Committees are reliant on inspectors general and whistle-blowers to conduct their constitutionally mandated oversight over federal agencies and even the president of the United States.”
A version of this article appears in print on March 2, 2020, Section A, Page 27 of the New York edition with the headline, Those Who Tell Need Urgent Help.
To read the OpEd online, click here.
On Friday, January 31, 2020, the Metropolitan Washington Employment Lawyers Association named Andrew P. Bakaj and his co-counsel, Mark S. Zaid, “Lawyers of the Year” for their work representing the Intelligence Community Whistleblower whose disclosure led to the 2019 Impeachment Inquiry.
Bakaj represented the whistleblower from the beginning, guiding the individual towards the Intelligence Community Inspector General disclosure process. Zaid joined the case after it became public that the disclosure was not transmitted to Congress. Bakaj and Zaid represented the client’s interests throughout the process.
The MWELA “Lawyer of the Year” award is bestowed annually to one or two employment attorneys in the Washington, DC region whose significant accomplishments embody the mission of the association to advance and protect the rights of individuals.
MWELA is a 501(c)(4) organization comprised of over 300 lawyers who regularly advise and represent employees in employment and civil rights disputes. MWELA is the local chapter of the National Employment Lawyers Association, a national organization of more than 3,000 lawyers dedicated to the advancement of employee rights.
To learn more about MWELA, click here.
I. Charles McCullough, Partner with Compass Rose Legal Group, was Interviewed by The Hill about the Department of Justice Inspector General Report of Investigation into former FBI Director Comey. To red the article, please click here.
By David Brown / Jun 18, 2019
Prescription drug problems are the number one thing flagging candidates during polygraph examinations these days—and not for reasons you might think. Trading prescription medications—think: sharing Adderall in college, or offering a pain pill when a friend pulls her back—can disqualify you from getting a security clearance because agencies consider that “intent to distribute illegal narcotics.” Unlike, say, experimenting with cocaine that one time several years ago—something adjudicators might still rule favorably on—handing out your Adderall is an issue, and it is snagging a lot of job candidates.
“The SF-86 covers it, but it seems like these things always come up in polygraphs,” says Charles McCullough, a partner with the Compass Rose Legal Group, and the former Inspector General of the Intelligence Community. “It pops up with onboard people during their five-year re-investigations, and it pops up with new applicants as well. If your spouse has a painkiller prescription for a dental issue, and you can’t sleep and decide to take some, that’s a problem from a clearance standpoint.”
McCullough adds that for a one-off situation like that, an onboard worker can expect disciplinary action, but his or her clearance probably won’t be revoked. A clearance applicant who has done drugs within the last twelve months, however, or who has a felony drug conviction, will almost certainly be disqualified.
“Minimizing” answers on the SF-86, or being somehow less than truthful, is the worst thing you can do when filling out the form. It’s never a bad idea to speak with an attorney before submitting the application to find out when and how answers should be best explained. Elisions of one’s personal history can come back to haunt an applicant when he or she is strapped to a polygraph machine.
“The polygraph, whether or not it’s good science, is basically an investigative and interviewing tool and it’s very effective,” says McCullough. Examinations are high pressure situations, and when people are hooked up to a polygraph, they tend quickly to become very, very honest about themselves. “The polygraph examiner is going to sit there with a yellow pad and pen and write everything down. The whole thing is being recorded. It’s being videotaped. It’s being audiotaped. And they’re going to say, ‘The needle isn’t bouncing your way. What’s wrong? What is it you are not telling me?’ And people tend to start disclosing everything over and over and over again, and if they haven’t already disclosed it on the form—if they minimized it on the SF-86 when they first applied—now we have an integrity issue. We’ve gone from just having a drug issue to having a personal conduct issue as well.”
And that could be disqualifying. Another ghost that tends to haunt people is the SF-86 that they completed many years earlier. When you are young, you think: Well, I only need a secret clearance and I don’t have to take a polygraph… so why complicate things with messy admissions like sharing a few pills? A decade later, however, an older, wiser cleared worker with three kids and a mortgage is offered a big promotion or a job at a defense contractor… and suddenly they need a Top Secret/SCI clearance with a poly. That SF-86 that was filled out ten years ago is still around, and suddenly those minimizations years earlier are back in a big way.
“When people fill out the SF-86, they really need to make sure they get it all down,” says McCullough. Adjudicators aren’t robots; they understand that life can be a little messy, and they use what is called a “whole person assessment” when deciding whether someone is eligible for a security clearance. “Obviously someone who is trafficking in heroin is going to be disqualified. But that’s not necessarily so for people who, say, experimented with drugs in college. Adjudicators are going to ask: What was the level of experimentation? Was it truly experimentation? Was there a habit? Was there addiction involved? Did they sell it? If they bought it, where did they get it from? Did they resell it to classmates? There are all sorts of permutations that have to be looked at, and it is looked at on a case-by-case basis. There is a contemplative process that takes place.”
Drug laws and prosecutions in general are complicated affairs, which makes your SF-86 and subsequent polygraph even more of a minefield. Steal a car from the BMW dealership, and you are probably going to be arrested for stealing a car. Prescription drug crimes have a lot more nuance.
“In the federal system, it depends entirely on the specific facts of the situation, and how it’s charged,” says Jessica Carmichael, a federal criminal defense lawyer with Ayotte, Carmichael, Ellis, & Brock, a law firm in Virginia. “Giving prescription medication to your friend could create a number of criminal liabilities, ranging from misdemeanor to felony charges.”
And the fact that you didn’t end up in a courtroom is no excuse to conveniently forget to mention your drug arrest on the clearance application. “If you are arrested and charged,” says Carmichael, “and that charge is dismissed by the prosecutor—in other words, he or she elected not to proceed with the prosecution—typically that charge is still going to show up on your record.”
In any event, Carmichael says, almost any defense attorney will tell you to never make statements without a lawyer present. “Always be polite and respectful and at the first possible opportunity, ask to speak with an attorney.”
On Sunday, May 5, 2019, Managing Partner Andrew P. Bakaj appeared on Washington, DC’s FOX 5 program “On the Hill” to discuss the legal issues involving the Attorney General Barr, Congress, and the Mueller Report.
To watch the segment, click here.
.
